Tag Archives: COVID-19

In the dispute between AstraZeneca and European Commission, the Belgian Court does not mention (in point IV. A. of the Decision) art. 25 of Regulation (EU) 1215/2012 Of the European Parliament and of the Council. This article states that “[i]f the parties, regardless of their domicile, have agreed that a court or the courts ofContinue reading “Some questions about the first decision of the Belgian court in the dispute between AstraZeneca and the European Commission”